-
Mashup Score: 1Secret US Navy sonar detected Titan implosion HOURS after last contact - 11 month(s) ago
The U.S. Navy detected the sound of the missing Titanic tourist submersible imploding shortly after it was reported missing, a senior Naval official told The Wall Street Journal.
Source: Mail OnlineCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 6Titanic sub search - live: Debris found in search is 'landing frame and rear cover from sub', expert says; Coast Guard to give update - 11 month(s) ago
The US Coast Guard has issued a major update, reporting that a debris field was discovered in the search area near the Titanic. Experts are said to be “evaluating the information”, and an update will be given at 8pm UK time.
Source: Sky NewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 2
Marc-Oliver Grimm joins Pedro Barata in a discussion on the final results of the TITAN-RCC trial, assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC). The TITAN-RCC was designed many years ago, when nivolumab + ipilimumab (NIVO/IPI) was not approved yet as a first-line treatment. During this time the pivotal CheckMate 214 trial was still in…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Marc-Oliver Grimm joins Pedro Barata in a discussion on the final results of the TITAN-RCC trial, assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC). The TITAN-RCC was designed many years ago, when nivolumab + ipilimumab (NIVO/IPI) was not approved yet as a first-line treatment. During this time the pivotal CheckMate 214 trial was still in…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Marc-Oliver Grimm joins Pedro Barata in a discussion on the final results of the TITAN-RCC trial, assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC). The TITAN-RCC was designed many years ago, when nivolumab + ipilimumab (NIVO/IPI) was not approved yet as a first-line treatment. During this time the pivotal CheckMate 214 trial was still in…
Source: UroTodayCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1
Marc-Oliver Grimm joins Pedro Barata in a discussion on the final results of the TITAN-RCC trial, assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC). The TITAN-RCC was designed many years ago, when nivolumab + ipilimumab (NIVO/IPI) was not approved yet as a first-line treatment. During this time the pivotal CheckMate 214 trial was still in…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Marc-Oliver Grimm joins Pedro Barata in a discussion on the final results of the TITAN-RCC trial, assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC). The TITAN-RCC was designed many years ago, when nivolumab + ipilimumab (NIVO/IPI) was not approved yet as a first-line treatment. During this time the pivotal CheckMate 214 trial was still in…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
ESMO 2022 TITAN-RCC trial, TITAN-RCC trial assessing a tailored approach to systemic therapy in patients with metastatic renal cell carcinoma (mRCC)
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Efficacy of a tailored approach with nivolumab and nivolumab/ipilimumab as an immunotherapeutic boost in metastatic #RenalCellCarcinoma. Final results of #TITAN-RCC. Presented by @grimm_mo @UKJ_Jena. #ESMO22 written coverage by @WallisCJD @UofT > https://t.co/2EV7ROpAev @myESMO https://t.co/F64Dta0XNe
-
-
Mashup Score: 5ASCO 2022: Genomic Aberrations Associated with Overall Survival in mCSPC Treated with Apalutamide or Placebo + ADT in TITAN - 2 year(s) ago
ASCO 2022 TITAN trial, genomic aberrations associated with overall survival in mCSPC treated with apalutamide or placebo + ADT, TITAN biomarker population, Circulating tumor (ct)DNA and genomic aberrations, data from TITAN.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Kim Chi, MD @BCCancer #TITAN #ProstateCancer #Cancer #R - 2 year(s) ago
Kim Chi, MD, Vice President & Chief Medical Officer of BC Cancer speaks about TITAN: A final analysis with close to four years of follow-up data evalua
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Top secret US Navy sonar detected Titan sub implosion HOURS after submersible lost contact. #titan #titanic https://t.co/CeUIH9q9JO